Disabling survival pathways could be a promising strategy for brain tumor treatment
When you disable the brakes on a race car, it quickly crashes. Dr. Barak Rotblat wants to do something similar to brain cancer cells. He wants to disable their ability to survive glucose starvation....
Insilico and NVIDIA unveil new LLM transformer for solving biological and chemical tasks
In a new paper, researchers from clinical stage artificial intelligence (AI)-driven drug discovery company Insilico Medicine ("Insilico"), in collaboration with NVIDIA, present a new large language model (LLM) transformer for solving biological and chemical...
World-first trial shows benefits of finding, treating undiagnosed asthma and COPD
Finding and treating people with undiagnosed asthma or chronic obstructive pulmonary disease (COPD) improved their health and reduced their healthcare visits for respiratory symptoms in the year after diagnosis, according to a world-first clinical...
JAK Attack: Ajax Takes Aim at Myelofibrosis
Drug development based on Janus kinase (JAK) inhibitors hasn’t progressed as far as other biopharma specialties since the first such treatment won approval more than a decade ago.
Ajax Therapeutics, a drug developer created to...
Insilico Medicine introduces nach0: A one-stop LLM for chemical and biomedical tasks
In a new paper, researchers from clinical stage artificial intelligence (AI)-driven drug discovery company Insilico Medicine (“Insilico”), in collaboration with NVIDIA, present a new large language model (LLM) transformer for solving biological and chemical...
Virginia Tech physicists propose path to faster, more flexible robots
In a May 15 paper released in the journal Physical Review Letters, Virginia Tech physicists revealed a microscopic phenomenon that could greatly improve the performance of soft devices, such as agile flexible robots or...
Maximizing Manufacturing Productivity with a Continuous Chromatography Process
REGISTER NOW
Broadcast Date: Thursday, June 27, 2024Time: 8:00 am PT, 11:00 am ET, 17:00 CEST
Biologics manufacturers are under increasing pressure to reduce production costs. This is a key driver for moving...
StockWatch: Like a Bolt from the Blue, Cancer Drug Developer Nosedives
Willie Quinn, Bolt Biotherapeutics CEO
When it launched in 2015, Bolt Biotherapeutics (BOLT) took a name intended to suggest dramatic effectiveness for its cancer treatments. But this past week, the name reflected convulsions ranging from...
ACM and CSTA announce 2023–24 Cutler-Bell student winners
The Association for Computing Machinery (ACM) and the Computer Science Teachers Association (CSTA) announced four high school students were selected from among a pool of graduating high school seniors throughout the US for the...
Study demonstrates link between disrupted developmental dopamine signaling and ASD
Recent evidence suggests that dopamine plays a crucial role in neural development. In a novel study, investigators demonstrated the link between disrupted developmental dopamine signaling and autism spectrum disorder (ASD). Their findings underscore the...
